• Decrease font size
  • Default font           size
  • Increase font size
Prosonix Shortlisted for CPHI 2006 Innovation Award PDF Print E-mail
Tuesday, 19 December 2006 12:53
Prosonix-Shortlisted-for-InProsonix (Oxford UK) are delighted to announce that for the second year in succession, they have been short listed for the CPhI Worldwide Innovation Award, for their new SAXTM particle engineering technology, which has been under development in partnership with Dr Rob Price of the University of Bath (Bath, UK). This international peer recognition of the potential of SAXTM (Solution Atomization and Sonocrystallization) follows on from their CPhI Worldwide 2005 Innovation Award Gold Medal success for CrystalGEMTM, and confirms Prosonix’s status as an acknowledged world leader in the commercialisation of cutting edge technology in pharmaceutical ultrasonic process chemistry.
Last Updated on Sunday, 18 January 2009 19:41
 

Latest News

03 Feb 2012 - Geoff Down appointed as Chief Medical Officer
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
More in: Latest

Events

Respiratory Drug Delivery 2012
10 October 2011 08:57
article thumbnai